Mimedx (MDXG) Cash from Operations Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -64.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.54% |
| Dec 31, 2025 | 26.60% |
| Sep 30, 2025 | 56.89% |
| Jun 30, 2025 | -36.60% |
| Mar 31, 2025 | -11.36% |
| Dec 31, 2024 | 92.18% |
| Sep 30, 2024 | 46.15% |
| Jun 30, 2024 | 192.53% |
| Mar 31, 2024 | 247.68% |
| Dec 31, 2023 | 138.70% |
| Sep 30, 2023 | 1,233.79% |
| Jun 30, 2023 | 358.74% |
| Mar 31, 2023 | 60.40% |
| Dec 31, 2022 | 138.63% |
| Sep 30, 2022 | -84.85% |
| Jun 30, 2022 | -287.93% |
| Mar 31, 2022 | -53.06% |
| Dec 31, 2021 | -8.35% |
| Sep 30, 2021 | 237.07% |
| Jun 30, 2021 | 151.63% |
| Mar 31, 2021 | 45.62% |
| Dec 31, 2020 | 55.60% |
| Sep 30, 2020 | -46.14% |
| Jun 30, 2020 | -245.40% |
| Mar 31, 2020 | 19.52% |
| Dec 31, 2019 | -1,607.30% |
| Sep 30, 2019 | -193.02% |
| Jun 30, 2019 | -89.70% |
| Mar 31, 2019 | -249.96% |
| Dec 31, 2018 | -92.65% |
| Sep 30, 2018 | -81.08% |
| Jun 30, 2018 | 53.45% |
| Mar 31, 2018 | -4.36% |
| Dec 31, 2017 | 41.93% |
| Sep 30, 2017 | 530.97% |
| Jun 30, 2017 | 85.21% |
| Mar 31, 2017 | 1,189.05% |
| Dec 31, 2016 | 237.49% |
| Sep 30, 2016 | -61.07% |
| Jun 30, 2016 | 148.21% |
| Mar 31, 2016 | -123.21% |
| Dec 31, 2015 | -47.43% |
| Sep 30, 2015 | -18.33% |
| Jun 30, 2015 | 148.56% |
| Mar 31, 2015 | 361.17% |
| Dec 31, 2014 | 885.65% |
| Sep 30, 2014 | 417.56% |
| Jun 30, 2014 | 256.22% |
| Mar 31, 2014 | 23.17% |
| Dec 31, 2013 | 196.53% |
| Sep 30, 2013 | 300.50% |
| Jun 30, 2013 | -142.98% |
| Mar 31, 2013 | -62.91% |
| Dec 31, 2012 | 47.40% |
| Sep 30, 2012 | 20.86% |
| Jun 30, 2012 | 85.40% |
| Mar 31, 2012 | 28.04% |